All In Biotech

Drug Trial Radar · NCT01294163

Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

Efficacy and Safety of Xenon Anaesthesia Compared to Sevoflurane Anaesthesia and Total Intravenous Anaesthesia for On-pump Coronary Artery Bypass Graft Surgery: a Randomised, Three-arm, Single-blind, International Study

Last checked: Nov 20, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 509 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

509

Actual

Start

Apr 2011

Primary completion

Apr 2014

Study completion Apr 2014

Sponsor

Sponsor type
Industry
Collaborators
Orion Corporation, Orion Pharma
First posted
Feb 11, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Xenon is a gaseous anaesthetic agent registered in several European countries. It has been administered safely during cardiac surgery in pilot studies. In animal studies, xenon decreases the size of experimental myocardial infarction. This 3-arm study will compare xenon, sevoflurane and a propofol-based total intravenous anaesthesia for maintenance of anaesthesia during coronary artery bypass graft surgery conducted with extra-corporeal circulation. Xenon and sevoflurane will be administered before and after extracorporeal circulation. Propofol will be administered during extracorporeal circulation in the three groups of patients. The study will compare the postoperative myocardial damage observed 24 hours after surgery from blood levels of troponin I, a largely accepted biomarker of myocardial necrosis. The main hypothesis is that the myocardial damage observed after xenon administration will not be superior to the damage observed after sevoflurane administration (non-inferiority). The second hypothesis is that the myocardial damage observed after xenon administration will be inferior to the damage observed after total intravenous anaesthesia.

Conditions

  • Coronary Artery Disease
  • General Anesthetic Drug Allergy
  • Coronary Artery Bypass Graft Surgery

Interventions

  • XenonDrug

    Inhaled xenon, maximal inspired concentration of 65%.

  • SevofluraneDrug

    Inhaled sevoflurane, maximal inspired concentration of 1.8%.

  • PropofolDrug

    Hourly dose of 2-4 mg/kg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Blood Level of Troponin ITime frame: Sampling performed 24 hours after the end of the surgical procedure
  2. Log-transformed Blood Level of Troponin ITime frame: Sampling performed 24 hours after the end of the surgical procedure

Locations

17 sites in 4 countries. Site status is shown where the registry gives one.

  • Hôpital Cardiovasculaire et Pneumologique Louis Pradel

    Bron, France

  • CHU de Caen

    Caen, France

  • Hôpital G&R Laennec - Centre Hospitalier Universitaire de Nantes

    Nantes, France

  • Centre Hospitalo-Universitaire Pitié-Salpetrière

    Paris, France

  • Hôpital du Haut-Lévêque

    Pessac, France

  • Hôpital Pontchaillou

    Rennes, France

  • Hôpitaux Universitaires de Strasbourg - Nouvel Hôpital Civil

    Strasbourg, France

  • Centre Hospitalier de Rangueil

    Toulouse, France

  • University Hospital Aachen

    Aachen, Germany

  • Klinikum Links der Weser - Senator-Wessling-Str. 1

    Bremen, Germany

  • University Hospital Frankfurt AM Main

    Frankfurt, Germany

  • UniversitatsKlinikum Schleswig-Holstein

    Lübeck, Germany

  • University Hospital ROSTOCK

    Rostock, Germany

  • Universitätsklinikum Schleswig-Holstein

    Kiel, Schleswig-Holstein, Germany

  • Policlinico Umberto I

    Rome, Italy

  • Academic Medical Center - University of Amsterdam

    Amsterdam, Netherlands

  • Thorax Center - Erasmus MC

    Rotterdam, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.